Aligos Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | — | $24.5M |
| Sep 2019 | — | — | $21.1M |
| Dec 2019 | $29.3M | $146.5M | $69.6M |
| Mar 2020 | — | — | $25.4M |
| Jun 2020 | — | — | $22.7M |
| Sep 2020 | $46.3M | $92.2M | $31.8M |
| Dec 2020 | $45.3M | $265.3M | $220.4M |
| Mar 2021 | $39.3M | $234.5M | $200.4M |
| Jun 2021 | $43.0M | $211.9M | $187.7M |
| Sep 2021 | $46.1M | $263.1M | $239.7M |
| Dec 2021 | $50.6M | $235.4M | $186.8M |
| Mar 2022 | $57.6M | $210.5M | $104.6M |
| Jun 2022 | $45.5M | $182.5M | $71.2M |
| Sep 2022 | $42.1M | $164.1M | $86.4M |
| Dec 2022 | $42.8M | $146.7M | $81.3M |
| Mar 2023 | $37.0M | $121.7M | $78.7M |
| Jun 2023 | $36.5M | $106.1M | $90.8M |
| Sep 2023 | $31.0M | $85.9M | $70.4M |
| Dec 2023 | $59.4M | $151.5M | $135.7M |
| Mar 2024 | $68.1M | $127.9M | $24.2M |
| Jun 2024 | $41.6M | $108.8M | $45.1M |
| Sep 2024 | $38.3M | $88.4M | $35.3M |
| Dec 2024 | $99.1M | $70.1M | $37.0M |
| Mar 2025 | $34.3M | $150.7M | $73.8M |
| Jun 2025 | $32.8M | $134.7M | $18.7M |
| Sep 2025 | $37.9M | $109.8M | $41.9M |
| Dec 2025 | $35.0M | $88.5M | $18.3M |
| Mar 2026 | $32.8M | $64.6M | $30.0M |
| Jun 2026 | $34.4M | $66.3M | $30.4M |